产品详情
In vitro (25°C) | DMSO | 59 mg/mL (192.57 mM) | |
Water | Insoluble | ||
Ethanol | 59 mg/mL (192.57 mM) | ||
In vivo | 2% DMSO+30% PEG 300+ddH2O | 4 mg/mL | |
* <1 mg/ml means slightly soluble or insoluble. * Please note that Adooq tests the solubility of all compounds in-house, and the actual solubility may differ slightly from published values. This is normal and is due to slight batch-to-batch variations. |
Concentration / Solvent Volume / Mass | 1 mg | 5 mg | 10 mg |
---|---|---|---|
0.1 mM | 32.64 mL | 163.19 mL | 326.37 mL |
0.5 mM | 6.53 mL | 32.64 mL | 65.27 mL |
1 mM | 3.26 mL | 16.32 mL | 32.64 mL |
5 mM | 0.65 mL | 3.26 mL | 6.53 mL |
*The above data is based on the productmolecular weight 306.4 . Batch specific molecular weights may vary from batch to batch due to solvent of hydration, which will affect the solvent volumes required to prepare stock solutions.
目录号 | A11041 |
---|---|
作用机制 | Inhibitor (抑制剂) |
M. Wt | 306.4 |
Formula | C17H18N6 |
Purity | >99% |
Storage | Store lyophilized at -20ºC, keep desiccated. |
CAS No. | 941678-49-5 |
Synonyms | Ruxolitinib, INCB18424 |
SMILES | C1CCC(C1)[C@@H](CC#N)N2C=C(C=N2)C3=C4C=CNC4=NC=N3 |
产品资料
产品标签
Product Questions
Product Questions
R406 besylate
R406 besylate是一种口服酪氨酸激酶抑制剂,IC50为41 nM。对Syk抑制作用强,但是不抑制Lyn,对Flt3的作用比对Syk…
Filgotinib
Filgotinib是一种选择性的JAK1抑制剂,对于JAK1,JAK2,JAK3和TYK2的IC50分别为10 nM,28 nM,810 nM和116 nM。
AC220 (Quizartinib)
AC220 (Quizartinib)是一种有效的选择性FLT3抑制剂,对于MC4-11和A375,IC50分别为0.56±0.3 nM和> 10 mM。
TG-101348 (Fedratinib, SAR302503)
TG-101348 (Fedratinib,SAR302503)是Janus相关激酶2的口服生物利用型,ATP竞争性和选择性抑制剂,在无细胞试验中IC5…